Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized trial for troublesome bleeding in Implanon users
ACTRN12611000617965Phase 4Not yet recruiting
- Sponsor
- Dr Edith Weisberg
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of desogestrel, etonogestrel + ethinyl estradiol and Placebo-COD Research Private Ltd in menstrual disorders (4 arms), sponsored by Dr Edith Weisberg. Primary endpoints: Days to stop bleeding after treatment initiation and Immediate post-treatment bleeding and spotting days versus placebo. Planned start Jul 2011; status: not yet recruiting.
02
Drugs
desogestreletonogestrel + ethinyl estradiolPlacebo-COD Research Private Ltd
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on ACTRN12611000617965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000617965.